星昊医药
(430017)
| 流通市值：30.59亿 | | | 总市值：30.80亿 |
| 流通股本：1.21亿 | | | 总股本：1.22亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 491,298,314.64 | 465,947,571.03 | 255,892,806.05 | 232,515,743.52 |
| 应收票据及应收账款 | 82,063,645.07 | 85,668,258.01 | 94,909,430.85 | 78,438,391.22 |
| 其中：应收票据 | 15,663,675.45 | 14,242,031.28 | 10,641,192.44 | 7,370,317.19 |
| 应收账款 | 66,399,969.62 | 71,426,226.73 | 84,268,238.41 | 71,068,074.03 |
| 应收款项融资 | 8,788,835.27 | 5,562,841.97 | 50,849,550.92 | 56,242,253.71 |
| 预付款项 | 6,669,725.9 | 3,092,607.37 | 3,848,798.5 | 3,996,738.33 |
| 其他应收款合计 | 6,335,847.9 | 6,570,574.1 | 4,012,475.15 | 3,815,171.93 |
| 存货 | 60,751,055.24 | 58,167,216.7 | 73,204,801.66 | 80,168,385.88 |
| 一年内到期的非流动资产 | 21,353,808.15 | - | - | - |
| 其他流动资产 | 6,708,150.17 | 15,855,095.53 | 1,157,699.89 | 798,123.77 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 985,935,371.37 | 912,389,192.12 | 982,566,267.12 | 979,569,165.91 |
| 非流动资产: | | | | |
| 长期股权投资 | 7,734,382.96 | 7,964,083.48 | 7,922,419.99 | 8,054,811.17 |
| 其他权益工具投资 | 10,820,153.45 | 10,820,153.45 | 9,259,671.37 | 9,259,671.37 |
| 固定资产 | 636,294,803.41 | 646,509,366.99 | 623,284,659.97 | 633,880,672.48 |
| 在建工程 | 94,043,687.92 | 67,031,884.87 | 48,934,849.09 | 43,210,161.84 |
| 无形资产 | 73,350,694.31 | 75,062,511.01 | 77,081,592.32 | 78,977,525.33 |
| 长期待摊费用 | 34,403.67 | 68,807.34 | 106,880.87 | 394,952.93 |
| 递延所得税资产 | 26,376,268.38 | 28,651,491.22 | 30,323,639.98 | 33,051,567.72 |
| 其他非流动资产 | 59,071,619.15 | 97,816,390.91 | 107,386,247.56 | 102,660,115.75 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 907,726,013.25 | 933,924,689.27 | 904,299,961.15 | 909,489,478.59 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,893,661,384.62 | 1,846,313,881.39 | 1,886,866,228.27 | 1,889,058,644.5 |
| 流动负债: | | | | |
| 短期借款 | 10,008,555.56 | 10,008,555.56 | 13,447,993.49 | 20,398,949.89 |
| 应付票据及应付账款 | 86,747,239.54 | 50,212,680.78 | 115,232,620.46 | 117,084,472.01 |
| 其中：应付票据 | 49,988,070.76 | 18,519,570 | 64,723,570 | 69,748,750 |
| 应付账款 | 36,759,168.78 | 31,693,110.78 | 50,509,050.46 | 47,335,722.01 |
| 合同负债 | 30,920,097.82 | 33,792,769.6 | 48,872,302.39 | 48,581,087.13 |
| 应付职工薪酬 | 6,719,040.56 | 11,853,152.15 | 7,315,959.02 | 7,450,863.04 |
| 应交税费 | 3,943,706.26 | 5,591,888.91 | 8,698,601.21 | 8,074,774.09 |
| 其他应付款合计 | 46,401,054.18 | 50,635,750.2 | 54,434,620.79 | 57,190,088.22 |
| 其他流动负债 | 16,089,153.05 | 11,929,796.02 | 6,734,078.05 | 7,867,696.65 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 200,828,846.97 | 174,024,593.22 | 254,736,175.41 | 266,647,931.03 |
| 非流动负债: | | | | |
| 预计负债 | 30,000,000 | 30,000,000 | - | - |
| 递延收益 | 97,634,156.43 | 102,151,136.59 | 104,917,693.27 | 109,452,872.63 |
| 递延所得税负债 | 1,897,295.16 | 1,869,182.71 | 1,709,348.36 | 1,806,618.65 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 129,531,451.59 | 134,020,319.3 | 106,627,041.63 | 111,259,491.28 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 330,360,298.56 | 308,044,912.52 | 361,363,217.04 | 377,907,422.31 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 122,288,200 | 122,288,200 | 122,577,200 | 122,577,200 |
| 资本公积 | 715,174,556.03 | 715,174,556.03 | 713,346,683.96 | 713,346,683.96 |
| 减:库存股 | 15,565,242.81 | 15,565,242.81 | 21,239,402.81 | 18,219,402.81 |
| 其他综合收益 | 653,527.39 | 652,507.11 | -787,834.3 | -785,773.1 |
| 盈余公积 | 49,958,365.39 | 49,958,365.39 | 44,223,186.94 | 44,223,186.94 |
| 未分配利润 | 690,791,680.06 | 665,760,583.15 | 667,383,177.44 | 649,041,666.07 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,563,301,086.06 | 1,538,268,968.87 | 1,525,503,011.23 | 1,510,183,561.06 |
| 少数股东权益 | - | 0 | - | 967,661.13 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,563,301,086.06 | 1,538,268,968.87 | 1,525,503,011.23 | 1,511,151,222.19 |
| 负债和股东权益合计 | 1,893,661,384.62 | 1,846,313,881.39 | 1,886,866,228.27 | 1,889,058,644.5 |
| 公告日期 | 2025-04-28 | 2025-04-23 | 2024-10-28 | 2024-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |